4//SEC Filing
Dipexium Pharmaceuticals, Inc. 4
Accession 0001104659-15-005436
CIK 0001497504operating
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:12 PM ET
Size
5.3 KB
Accession
0001104659-15-005436
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident, CEO, Secretary10% Owner
Transactions
- Award
Options
2015-01-05$11.35/sh+35,000$397,250→ 333,826 totalExercise: $11.35Exp: 2020-01-05→ Common stock, $0.001 par value per share (35,000 underlying)
Footnotes (1)
- [F1]Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period, subject to accelerated vesting on a change of control.
Documents
Issuer
Dipexium Pharmaceuticals, Inc.
CIK 0001497504
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001497504
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 5:12 PM ET
- Size
- 5.3 KB